Platelet-rich plasma: a comparative and economical therapy for wound healing and tissue regeneration

Cell Tissue Bank. 2023 Jun;24(2):285-306. doi: 10.1007/s10561-022-10039-z. Epub 2022 Oct 12.

Abstract

Rise in the incidences of chronic degenerative diseases with aging makes wound care a socio-economic burden and unceasingly necessitates a novel, economical, and efficient wound healing treatment. Platelets have a crucial role in hemostasis and thrombosis by modulating distinct mechanistic phases of wound healing, such as promoting and stabilizing the clot. Platelet-rich plasma (PRP) contains a high concentration of platelets than naïve plasma and has an autologous origin with no immunogenic adverse reactions. As a consequence, PRP has gained significant attention as a therapeutic to augment the healing process. Since the past few decades, a robust volume of research and clinical trials have been performed to exploit extensive role of PRP in wound healing/tissue regeneration. Despite these rigorous studies and their application in diversified medical fields, efficacy of PRP-based therapies is continuously questioned owing to the paucity of large samplesizes, controlled clinical trials, and standard protocols. This review systematically delineates the process of wound healing and involvement of platelets in tissue repair mechanisms. Additionally, emphasis is laid on PRP, its preparation methods, handling, classification,application in wound healing, and PRP as regenerative therapeutics combined with biomaterials and mesenchymal stem cells (MSCs).

Keywords: Biomaterials; Growth factors; Mesenchymal stem cells; Platelet; Platelet-rich plasma; Wound healing.

Publication types

  • Review

MeSH terms

  • Biocompatible Materials
  • Blood Platelets
  • Humans
  • Mesenchymal Stem Cells*
  • Platelet-Rich Plasma*
  • Wound Healing

Substances

  • Biocompatible Materials